Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Immunology patent intelligence

Autoimmune, rheumatology, and immunology biologic patents — biosimilar entry timing signals.

Patents
194

Quick answer

194 US pharmaceutical patents in our index match Immunology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6083503

    Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6033864

    Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens

    The Regents of the University of California · Granted Tue Mar 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Immunology patents are indexed?

194 patents match our Immunology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.